This World Alzheimer’s Month, we’re calling on government to deliver on its manifesto promise to double dementia research funding. But we need your help.

In its 2019 Manifesto, the government vowed to boost investment to over £160 million a year to find a cure for dementia. But we have not heard how or when this funding will be made available.

With 95% of dementia researchers having had projects delayed, and one in five having projects cut due to COVID-19, this investment is needed now more than ever before. Without it, life-changing research will be put on hold and future treatments may face delays.

That’s why we’re asking you to stand with us and speak up for everyone affected by dementia.

Hold government to account.

Write to your MP

Share the report and ask your MP to support our delivery plan.

Dementia research is at risk

Read why government must act now.

Share on social media

Encourage others to get involved.

Campaign with us

Keep dementia a priority by becoming a Campaigner.

Delivering the Dementia Moonshot: A plan to find life-changing treatments

Senior man on the coast. Its cold outside so they are wrapped up warm. The man is carrying a little girl in his arms

January 2020

Alzheimer’s Research UK has called on government to invest in six priority research areas, which will help to deliver a life-changing treatment for dementia.

In their 2019 manifesto, the Conservative party pledged to launch a “Dementia Moonshot” to find a cure for dementia - doubling research funding and speeding up trials for new treatments.

Now we need to see action to deliver on those commitments. Our plan outlines the steps government must take to deliver its Moonshot ambition of finding a life-changing treatment for dementia.

These are:

  1. Find ways to detect the diseases that cause dementia 10-15 years earlier, to broaden the search for new treatments and intervene with those most at risk of developing dementia.
  2. Find ways to more effectively validate novel targets in early drug development to maximise chances of successful clinical trials.
  3. Make the UK the best place to conduct clinical dementia research.
  4. Expand research infrastructure to maintain the UK’s position as a world leader in dementia research.
  5. Further our understanding of dementia risk reduction and prevention and dementia in the context of multi-morbidities.
  6. Develop robust prevalence data for dementia to further our knowledge of the impact of dementia across our society.